Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms

Abstract

The delivery of antigenic proteins in the context of a DNA vaccine leads to the intracellular synthesis of antigen and the induction of both humoral and cellular immune responses. Subsequent to immune activation, any transfected cell expressing the immunogenic protein should, by the rules of immunology, become a legitimate target for removal by immune-mediated mechanisms. Herein, we have used an indirect assay of myocyte integrity following intra-muscular (i.m.) delivery of a DNA vaccine, in mice with various immune deficiencies, to determine which immunological mechanisms may be involved in destruction of antigen-expressing cells. We demonstrate that destruction of antigen-expressing myocytes following i.m. injection of a DNA vaccine is dependent on major histocompatability complex (MHC) class II restricted CD4+ T cell activation, but is not mediated solely by MHC I-restricted or perforin-mediated lysis and appears to have a component that is antibody-mediated. Although we studied myocytes, the results likely represent what happens to any transfected cell expressing a foreign antigen. This study underscores the ability of DNA vaccines at inducing antigen-specific immune responses that include a number of effector mechanisms. From the perspective of gene therapy, this study highlights the significance of immune activation when considering strategies where maintenance of therapeutic gene expression is desired. Gene Therapy (2001) 8, 1395–1400.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Davis HL, Michel ML, Whalen RG . DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody Hum Molec Genet 1993 2: 1847–1851

    Article  CAS  PubMed  Google Scholar 

  2. Davis HL et al. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen Vaccine 1994 12: 1503–1509

    Article  CAS  PubMed  Google Scholar 

  3. Davis HL, Schirmbeck R, Reimann J, Whalen RG . DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein Hum Gene Ther 1995 6: 1447–1456

    Article  CAS  PubMed  Google Scholar 

  4. Kowalczyk DW, Ertl HC . Immune responses to DNA vaccines Cell Mol Life Sci 1999 55: 751–770

    Article  CAS  PubMed  Google Scholar 

  5. Davis HL, Mancini M, Michel ML, Whalen RG . DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost Vaccine 1996 14: 910–915

    Article  CAS  PubMed  Google Scholar 

  6. Wolff JA et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle Hum Mol Genet 1992 1: 363–369

    Article  CAS  PubMed  Google Scholar 

  7. Cheng L, Ziegelhoffer PR, Yang NS . In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment Proc Natl Acad Sci USA 1993 90: 4455–4459

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Davis HL, Millan CL, Watkins SC . Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA Gene Therapy 1997 4: 181–188

    Article  CAS  PubMed  Google Scholar 

  9. Zijlstra M et al. Beta 2-microglobulin deficient mice lack CD4–8+ cytolytic T cells Nature 1990 344: 742–746

    Article  CAS  PubMed  Google Scholar 

  10. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH . Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice Science 1991 253: 1417–1420

    Article  CAS  PubMed  Google Scholar 

  11. Klavinskis LS, Barnfield C, Gao L, Parker S . Intranasal immunization with plasmid DNA–lipid complexes elicits mucosal immunity in the female genital and rectal tracts J Immunol 1999 162: 254–262

    CAS  PubMed  Google Scholar 

  12. Schirmbeck R et al. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice J Virol 1995 69: 5929–5934

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Harty JT, Tvinnereim AR, White DW . CD8+ T cell effector mechanisms in resistance to infection Annu Rev Immunol 2000 18: 275–308

    Article  CAS  PubMed  Google Scholar 

  14. Gholson CF, Siddiqui A, Vierling JM . Cell surface expression of hepatitis B surface and core antigens in transfected rat fibroblast cell lines Gastroenterology 1990 98: 968–975

    Article  CAS  PubMed  Google Scholar 

  15. Chu CM, Liaw YF . Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B J Clin Pathol 1995 48: 470–473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Satoh O et al. Membrane structure of the hepatitis B virus surface antigen particle J Biochem (Tokyo) 2000 127: 543–550

    Article  CAS  Google Scholar 

  17. Michalak TI et al. Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B Clin Exp Immunol 1995 100: 227–232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Daeron M . Fc receptor biology Annu Rev Immunol 1997 15: 203–234

    Article  CAS  PubMed  Google Scholar 

  19. Machy P, Serre K, Leserman L . Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells Eur J Immunol 2000 30: 848–857

    Article  CAS  PubMed  Google Scholar 

  20. Mitchell DA, Nair SK, Gilboa E . Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells (published erratum appears in Eur J Immunol 1998; 28: 3891) Eur J Immunol 1998 28: 1923–1933

    Article  CAS  PubMed  Google Scholar 

  21. Knight SC, Askonas BA, Macatonia SE . Dendritic cells as targets for cytotoxic T lymphocytes Adv Exp Med Biol 1997 417: 389–394

    Article  CAS  PubMed  Google Scholar 

  22. Parajuli P et al. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing J Leukoc Biol 1999 65: 764–770

    Article  CAS  PubMed  Google Scholar 

  23. Cavazzana-Calvo M et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 2000 28: 669–672

    Article  Google Scholar 

  24. Wilson CB, Embree LJ, Schowalter D et al. Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration J Virol 1998 72: 7542–7550

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Halbert CL, Standaert TA, Wilson CB, Miller AD . Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure J Virol 1998 72: 9795–9805

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Kagi D et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice Nature 1994 369: 31–37

    Article  CAS  PubMed  Google Scholar 

  27. Davis HL, Whalen RG, Demeneix BA . Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression Hum Gene Ther 1993 4: 151–159

    Article  PubMed  Google Scholar 

  28. Krieg AM et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs Proc Natl Acad Sci USA 1998 95: 12631–12636

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Davis HL et al. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle Hum Gene Ther 1993 4: 733–740

    Article  CAS  PubMed  Google Scholar 

  30. Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 1976 72: 248–254

    Article  CAS  PubMed  Google Scholar 

  31. Davis HL et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen J Immunol 1998 160: 870–876

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Jocelyn Chandler, Brian Avery, George Condruit, and Chandimal Nicholas for their excellent technical support. This work was supported by a grant from the Medical Research Council of Canada to HLP. PJ Payette is a recipient of an Ontario Graduate Student Award and HL Davis is the recipient of an Ontario Ministry of Health Career Scientist Award.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Payette, P., Weeratna, R., McCluskie, M. et al. Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms. Gene Ther 8, 1395–1400 (2001). https://doi.org/10.1038/sj.gt.3301534

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301534

Keywords

This article is cited by

Search

Quick links